Biosimilar Newsletter Archive
-
04.18.24 -- Fine-Tuning Analytical Development Strategies For Every Phase
4/18/2024
04/18/24 Biosimilar Development Newsletter
-
04.17.24 -- Leverage Innovative Assays And Monitoring To Improve mAb Production
4/17/2024
04/17/24 Biosimilar Development Newsletter
-
04.14.24 -- Proactive BioPharma Supplier Management
4/14/2024
04/14/24 Biosimilar Development Newsletter
-
04.11.24 -- The Business of Biotech: Leaders in ADC Technologies
4/11/2024
04/11/24 Biosimilar Development Newsletter
-
04.11.24 -- Proactive BioPharma Supplier Management
4/11/2024
04/11/24 Biosimilar Development Newsletter
-
04.04.24 -- A New Model Approach To Drug Shortage Prevention
4/4/2024
04/04/24 Biosimilar Development Newsletter
-
03.28.24 -- Meet "MAM," The New Quality Control Strategy On the Block
3/28/2024
03/28/24 Biosimilar Development Newsletter
-
03.22.24 -- Packaging And Containment Insights To Get To Market Faster
3/22/2024
03/22/24 Biosimilar Development Newsletter
-
03.21.24 -- Biosimilars Forum Urges Congress To Reform PBMs
3/21/2024
03/21/24 Biosimilar Development Newsletter
-
03.14.24 -- Understanding & Navigating Diverse Regulatory Environments
3/14/2024
03/14/24 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more